Allulose, a rare sugar with sweetening power similar to sugar yet low in calories, is widely used globally but remains unapproved in Europe due to its classification as a novel food requiring stringent safety evaluations. This article explores the scientific, regulatory, and economic reasons behind the delay, its applications, and when it might gain European approval amid increasing global demand for healthier sweeteners.